The supplement aisle promises optimization. Sharper focus, better skin, a stronger immune system, longer life. But the trial data tells a more boring story: most pills do something measurable only when your blood levels are already low. Above a threshold, you’re paying for very expensive urine.
This isn’t a fringe view. It’s the conclusion repeated by Cochrane reviews, the U.S. Preventive Services Task Force, and most large randomized trials of multivitamins in healthy adults.
The deficiency-or-nothing pattern
Iron supplementation transforms anemic patients. In iron-replete people, it does little and may cause harm. Vitamin D pills lower fracture risk in nursing-home residents whose levels are floor-low; in well-nourished adults, the VITAL trial found no reduction in cancer or cardiovascular events. B12 reverses neurological symptoms in the deficient — typically vegans, the elderly, and people on metformin or PPIs. In everyone else, supplementing produces no clinical benefit.
The pattern repeats across nutrients. Below threshold, replacement is medicine. Above it, the body has no machinery to use the surplus, and the kidneys flush it out. This is why “more is better” rarely survives a randomized trial.
Where the marketing exploits the gap
Supplement labels use language carefully chosen to sound clinical without claiming clinical benefit. “Supports immune function.” “Promotes healthy energy levels.” These are structure-function claims, regulated under DSHEA, and they require almost no evidence. A bottle can promise to “support” a system the user already has working fine.
Influencers fill the rest of the gap. Stacks of ten or fifteen capsules get presented as performance routines, often by people whose underlying performance comes from genetics, training, and youth. Magnesium gets credit for sleep that better screen habits would deliver. Ashwagandha gets credit for calm that consistent exercise produces. The supplement is the visible variable, so it gets the credit.
When testing actually makes sense
Testing first is the rare move that aligns with the evidence. A basic panel — ferritin, vitamin D, B12, sometimes folate and TSH — costs less than a year of premium multivitamins and tells you whether you’re in the small group who will actually benefit. Pregnant people legitimately need folate. Older adults often need B12 and D. Strict vegans need B12 and sometimes iron. People on long-term acid blockers need monitoring. Athletes training heavily in indoor gyms in northern climates plausibly need D.
Outside those buckets, the case thins fast. Fish oil failed to reduce cardiovascular events in the largest contemporary trials. Antioxidant megadoses raised mortality slightly in meta-analysis. Glucosamine performed about as well as placebo for joint pain. The honest answer for most healthy adults is that a varied diet and a blood test beat a cabinet full of bottles.
The takeaway
Supplements aren’t snake oil, but they aren’t a strategy either. They are targeted tools that work when a specific gap exists and underperform when one doesn’t. Test before you stack. If the number is low, treat it. If it’s normal, save the money and put it toward food, sleep, or a gym membership that will actually move the needle.
Leave a Reply